Respiro-Fermentation: To breathe or not to breathe?

Listeria monocytogenes uses respiration to sustain a risky fermentative lifestyle during infection.
  1. Lauren C Radlinski
  2. Andreas J Bäumler  Is a corresponding author
  1. Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, United States

Bacteria are masters at tuning their metabolism to thrive in diverse environments, including during infection. Constant, life-or-death competition with host immune systems and other microorganisms rewards species that maximize the amount of energy they derive from limited resources.

Living organisms produce energy in the form of a small molecule called adenosine triphosphate (ATP). ATP is generated by breaking down, or oxidizing, high energy molecules such as sugars through a series of electron transfer reactions. These redox (reduction/oxidation) reactions require an intermediate electron carrier such as nicotine adenine dinucleotide (NADH) that must be re-oxidized (NAD+) in order for the cell to continue producing ATP by oxidizing high-energy electron donors.

During respiration, NAD+ is regenerated when electrons are transferred to a terminal electron acceptor such as oxygen. In organisms that cannot respire, ATP is produced through a less energy-efficient process called fermentation. Fermenting organisms also oxidize high-energy electron donors to produce ATP: however their strategy for regenerating NAD+ requires depositing electrons on an organic molecule such as pyruvate. Thus, fermenting organisms sacrifice potential ATP by producing waste products that are not fully oxidized.

Listeria monocytogenes is an important foodborne pathogen with an unusual metabolic strategy that falls somewhere between respiration and fermentation. This bacterium carries the genes for two respiratory electron transport chains that can use either oxygen or an extracellular metabolite such as fumarate or iron as a terminal electron acceptor (Corbett et al., 2017; Light et al., 2019). However, unlike most respiring organisms, L. monocytogenes lacks the enzymes required to fully oxidize sugars and instead produces partially reduced fermentative end products including lactic and acetic acid (Trivett and Meyer, 1971). Despite this, respiration is absolutely essential for L. monocytogenes to cause disease (Corbett et al., 2017) – in fact, mutants that cannot respire are considered safe enough to be used in vaccine development (Stritzker et al., 2004).

Now, in eLife, Samuel Light (University of Chicago) and colleagues – including Rafael Rivera-Lugo and David Deng (both from the University of California at Berkeley) as joint first authors – report on why respiration is essential for an organism that gets its energy through fermentation (Rivera-Lugo et al., 2022).

By comparing the waste products L. monocytogenes generates in the presence or absence of oxygen (a terminal electron acceptor), Rivera-Lugo et al. observed that oxygen shifts the composition of L. monocytogenes fermentative end products from primarily lactic to exclusively acetic acid. Compared to lactic acid, acetic acid is a slightly more oxidized waste product, the production of which generates more ATP but insufficient NAD+ to sustain itself. Thus, while acetic acid production generates more energy, it comes at the cost of redox balance, which could incur a potential reduction in cellular viability. Indeed, Rivera-Lugo et al. observed that genetically disrupting respiratory pathways inhibited L. monocytogenes growth within immune cells and prevented the bacterium from causing disease in mice.

Based on these results, Rivera-Lugo et al. surmised that L. monocytogenes relies on respiration either to re-oxidize the surplus NADH that results from acetic acid fermentation (and re-establish redox balance), or to generate proton motive force (PMF). PMF is generated when protons are pumped across the bacterial membrane during respiration. The energy stored in the resulting proton gradient can be used by the cell to power important cellular activities such as solute transport and motility.

Redox balance and PMF generation are difficult processes to separate as they involve the same cellular machinery. To determine which of the two is essential for the pathogenesis of L. monocytogenes, Rivera-Lugo et al. genetically modified the bacterium to express an unusual NADH oxidase (NOX) previously described in the bacterium Lactococcus lactis (Neves et al., 2002). NOX decouples the production of NAD+ and PMF by transferring electrons from NADH directly to oxygen without pumping protons across the membrane (Titov et al., 2016). This tool allowed the team to separate these two processes by restoring NAD+ regeneration, without increasing PMF. When Rivera-Lugo et al. expressed NOX in a L. monocytogenes mutant that cannot respire, NOX activity restored acetic acid production, intracellular growth, cell-to-cell spread, and pathogenesis of the bacterium. This result implies that the primary purpose for L. monocytogenes respiration during infection is NAD+ regeneration, not PMF production.

While balancing redox may allow L. monocytogenes to produce more ATP through the fermentation of acetic acid, it does not explain why a respiration-deficient mutant cannot grow in a host. During infection, L. monocytogenes infects and replicates within host cells, then commandeers the cell’s own machinery to spread to neighboring cells. In line with previous observations (Chen et al., 2017), Rivera-Lugo et al. report that genetically inhibiting respiration causes L. monocytogenes to lyse – burst open and die – within host cells.

When a bacterium lyses inside a cell, it releases a number of molecules that initiate an antimicrobial response and significantly reduce the bacterium’s ability to cause disease (Sauer et al., 2010). Thus, the tendency for a respiration-deficient mutant to lyse within host cells may inadvertently trigger the host's immune response and lead to clearance of the pathogen from the host. Rivera-Lugo et al. showed that restoring NAD+ regeneration with NOX stopped L. monocytogenes from lysing within infected cells and restored the bacterium’s ability to colonize a mouse. Together these findings imply that respiration-mediated redox balance is crucial for maintaining L. monocytogenes viability during infection (Figure 1).

Effects of inhibiting respiration in L. monocytogenes.

(A) L. monocytogenes uses respiration to restore redox balance during growth through acetic acid fermentation by transferring electrons from NADH to an electron acceptor such as oxygen (O2). This regenerates NAD+ to serve as an essential cofactor in the oxidative metabolic reactions that produce ATP. (B) Inhibiting respiration causes an imbalance between NAD+ and NADH, leading to NADH accumulation and lysis of L. monocytogenes during intracellular growth. This leads to a loss of pathogenesis.

The findings of Rivera-Lugo et al. address a long-standing mystery as to why respiration is required for successful L. monocytogenes infection. One outstanding question is how the accumulation of NADH leads to lysis. Understanding the molecular mechanism behind this phenomenon, and determining whether inhibiting respiration externally (with a drug, for example) leads to lysis, could reveal new therapeutic approaches for targeting organisms that employ similar respiro-fermentative metabolic strategies during systemic infection.

References

Article and author information

Author details

  1. Lauren C Radlinski

    Lauren C Radlinski is in the Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, United States

    Competing interests
    No competing interests declared
  2. Andreas J Bäumler

    Andreas J Bäumler is in the Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, United States

    For correspondence
    ajbaumler@ucdavis.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9152-7809

Publication history

  1. Version of Record published: May 20, 2022 (version 1)

Copyright

© 2022, Radlinski and Bäumler

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 876
    views
  • 115
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lauren C Radlinski
  2. Andreas J Bäumler
(2022)
Respiro-Fermentation: To breathe or not to breathe?
eLife 11:e79593.
https://doi.org/10.7554/eLife.79593

Further reading

    1. Biochemistry and Chemical Biology
    Pattama Wiriyasermkul, Satomi Moriyama ... Shushi Nagamori
    Research Article

    Transporter research primarily relies on the canonical substrates of well-established transporters. This approach has limitations when studying transporters for the low-abundant micromolecules, such as micronutrients, and may not reveal physiological functions of the transporters. While d-serine, a trace enantiomer of serine in the circulation, was discovered as an emerging biomarker of kidney function, its transport mechanisms in the periphery remain unknown. Here, using a multi-hierarchical approach from body fluids to molecules, combining multi-omics, cell-free synthetic biochemistry, and ex vivo transport analyses, we have identified two types of renal d-serine transport systems. We revealed that the small amino acid transporter ASCT2 serves as a d-serine transporter previously uncharacterized in the kidney and discovered d-serine as a non-canonical substrate of the sodium-coupled monocarboxylate transporters (SMCTs). These two systems are physiologically complementary, but ASCT2 dominates the role in the pathological condition. Our findings not only shed light on renal d-serine transport, but also clarify the importance of non-canonical substrate transport. This study provides a framework for investigating multiple transport systems of various trace micromolecules under physiological conditions and in multifactorial diseases.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Natalia Dolgova, Eva-Maria E Uhlemann ... Oleg Y Dmitriev
    Research Article

    Mediator of ERBB2-driven Cell Motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (TFR2), mitoferrin-2 (SLC25A28), and the global iron response regulator IRP1 (ACO1). These interactions indicate that cells with high MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.